Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXIV. Cytotoxic treatment is an additional risk factor for the development of symptomatic osteonecrosis in lupus patients: Results of a nested matched case-control study

1. Calvo-Alén, J.
2. McGwin, G.
3. Toloza, S.
4. Fernández, M.
5. Roseman, J.M.
6. Bastian, H.M.
7. Cepeda, E.J.
8. Gonzalez, E.B.
9. Baethge, B.A.
10. Fessler, B.J.
11. Vilá, L.M.
12. Reveille, J.D.
13. Alarcón, G.S.